Morgan Stanley Downgrades Adagene(ADAG.US) to Hold Rating
Adagene Downgraded to Equal Weight From Overweight at Morgan Stanley
Adagene Analyst Ratings
H.C. Wainwright Maintains Adagene(ADAG.US) With Buy Rating, Raises Target Price to $8
Jefferies Downgrades Adagene(ADAG.US) to Hold Rating, Cuts Target Price to $3.5
Adagene Downgraded to Hold From Buy at Jefferies
Jefferies Downgrades Adagene to Hold From Buy, Price Target Is $3.50
Adagene Analyst Ratings
H.C. Wainwright Maintains Adagene(ADAG.US) With Buy Rating, Maintains Target Price $5
Morgan Stanley Reaffirms Their Buy Rating on Adagene (ADAG)
Adagene Analyst Ratings
Adagene Analyst Ratings
Analysts Offer Insights on Healthcare Companies: EFFECTOR Therapeutics (EFTR), Adagene (ADAG) and Aquestive Therapeutics (AQST)
Analysts Conflicted on These Healthcare Names: Abbott Labs (ABT), Adagene (ADAG) and Teleflex (TFX)
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $5 Price Target
Adagene Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $5 Price Target
Adagene Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Oncternal Therapeutics (ONCT), Adagene (ADAG) and Omega Therapeutics (OMGA)
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $5 Price Target